Kaneka Corporation has reached an agreement with Fujifilm Corporation to supply drug substances for anti-influenza drug, Avigan Tablet (favipiravir), for the novel coronavirus disease, COVID-19.   While COVID-19 continues to spread, the Japanese government has decided to increase its stockpiles of Avigan Tablet, which is expected to be effective against COVID-19, for up to 2 million people, and Fujifilm Corporation has expanded its production system and started increasing its production of Aviga...